Adoptive T Cell Therapy investors in the United States.

Adoptive T Cell Therapy investors in the United States

This directory brings together 3 investor pages for Adoptive T Cell Therapy in the United States on Fliar. That is 3 investor lists. The list with the most capital behind it is Adoptive T Cell Therapy investors in San Francisco ($14.3B across the rounds it covers).

These are all the Adoptive T Cell Therapy investors in the United States we publish. For a wider view, see all Adoptive T Cell Therapy investor pages or everything in the United States.

Close neighbours of Adoptive T Cell Therapy are Cell Therapy, Gene Therapy, Antibody Based Immunotherapy, Cancer Immunotherapy, Immunology and Genomics for Drug Discovery.